*Soirindhri Banerjee1,
Ishika Mahajan2, Aruni
Ghose3,4,5,6,7, Stergios
Boussios5,8,9,10, Shivam
Chakraborty11
1Department of Radiation Oncology, Institute of Post
Graduate Medical Education & Research and SSKM Hospital, Kolkata,
India.
2Department of Haematology and Oncology, Lincoln
County Hospital, United Lincolnshire Hospitals Trust, Lincoln LN2 5QY
3Department of Medical Oncology, Barts Cancer Centre,
St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
4Department of Medical Oncology, Mount Vernon Cancer
Centre, East and North Hertfordshire NHS Trust, London, UK
5Department of Medical Oncology, Medway NHS Foundation
Trust, Kent, UK
6United Kingdom and Ireland Global Cancer Network
7Immuno-Oncology Clinical Network, UK
8Faculty of Life Sciences and Medicine, School of
Cancer and Pharmaceutical Sciences, King’s College London, London, UK
9Kent and Medway Medical School, University of Kent,
Canterbury, UK
10AELIA Organisation, 9th Km Thessaloniki – Thermi,
57001, Thessaloniki, Greece
11Depatment of Pathology, Institute of Post Graduate
Medical Education & Research and SSKM Hospital, Kolkata, India.
*Corresponding Author
Soirindhri Banerjee
Senior Resident
Department of Radiation Oncology, Institute of Post Graduate Medical
Education & Research and SSKM Hospital.
244, A J C Bose Road, Kolkata 700020, India.
Email – soirindhribanerjee@yahoo.co.in